These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6878427)
1. The three-dimensional dose distribution of 125I seeds in tissue. Hartmann GH; Schlegel W; Scharfenberg H Phys Med Biol; 1983 Jun; 28(6):693-9. PubMed ID: 6878427 [TBL] [Abstract][Full Text] [Related]
2. Physical dosimetry of 125I seeds of a new design for interstitial implant. Ling CC; Yorke ED; Spiro IJ; Kubiatowicz D; Bennett D Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1747-52. PubMed ID: 6643164 [TBL] [Abstract][Full Text] [Related]
3. Dose distribution for 125I implants due to anisotropic radiation emission and unknown seed orientation. Prasad SC; Bassano DA; Fear PI Med Phys; 1987; 14(2):296-8. PubMed ID: 3587158 [TBL] [Abstract][Full Text] [Related]
4. Some theoretical derivations relating to the tissue dosimetry of brachytherapy nuclides, with particular reference to iodine-125. Dale RG Med Phys; 1983; 10(2):176-83. PubMed ID: 6865856 [TBL] [Abstract][Full Text] [Related]
5. Review of eye plaque dosimetry based on AAPM Task Group 43 recommendations. American Association of Physicists in Medicine. Ray SK; Bhatnagar R; Hartsell WF; Desai GR Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):701-6. PubMed ID: 9635722 [TBL] [Abstract][Full Text] [Related]
6. Two-dimensional dose distribution around a commercial 125I seed. Burns GS; Raeside DE Med Phys; 1988; 15(1):56-60. PubMed ID: 3352551 [TBL] [Abstract][Full Text] [Related]
7. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed. Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418 [TBL] [Abstract][Full Text] [Related]
8. Interseed effects on dose for 125I brachytherapy implants. Meigooni AS; Meli JA; Nath R Med Phys; 1992; 19(2):385-90. PubMed ID: 1584137 [TBL] [Abstract][Full Text] [Related]
9. The NCI-atlas of dose distributions for regular 125I brain implants. Rosenow UF; Findlay PA; Wright DC Radiother Oncol; 1987 Oct; 10(2):127-39. PubMed ID: 3423302 [TBL] [Abstract][Full Text] [Related]
10. Absorbed dose determination for interstitial 125I boost therapy. Waterman FM; Strubler KA Med Phys; 1983; 10(2):155-8. PubMed ID: 6865855 [TBL] [Abstract][Full Text] [Related]
11. Monte Carlo evaluation of specific dose constants in water for 125I seeds. Williamson JF Med Phys; 1988; 15(5):686-94. PubMed ID: 3185403 [TBL] [Abstract][Full Text] [Related]
12. Dose rate constant and energy spectrum of interstitial brachytherapy sources. Chen Z; Nath R Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926 [TBL] [Abstract][Full Text] [Related]
13. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water. Wuu CS; Chen J Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276 [TBL] [Abstract][Full Text] [Related]
14. Two-dimensional dose distribution of 125I seeds. Ling CC; Schell MC; Yorke ED; Palos BB; Kubiatowicz DO Med Phys; 1985; 12(5):652-5. PubMed ID: 4047002 [TBL] [Abstract][Full Text] [Related]
15. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models. Thomson RM; Rogers DW Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499 [TBL] [Abstract][Full Text] [Related]
16. The exposure rate constant for a silver wire 125I seed. Hashemi AM; Mills MD; Hogstrom KR; Almond PR Med Phys; 1988; 15(2):228-34. PubMed ID: 3386595 [TBL] [Abstract][Full Text] [Related]
17. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants. Chibani O; Williamson JF; Todor D Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786 [TBL] [Abstract][Full Text] [Related]
18. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom. Chiu-Tsao ST; Medich D; Munro J Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938 [TBL] [Abstract][Full Text] [Related]